Page last updated: 2024-08-22

camptothecin and Muscular Dystrophy

camptothecin has been researched along with Muscular Dystrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barreto, R; Bonetto, A; Bonewald, LF; Colston, KC; Couch, KE; Couch, ME; Kitase, Y; Matsumoto, T; O'Connell, TM; Pin, F	1

Other Studies

1 other study(ies) available for camptothecin and Muscular Dystrophy

Article	Year
ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass. Scientific reports, 2017, 10-31, Volume: 7, Issue:1 Topics: Activin Receptors, Type II; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density; Cachexia; Camptothecin; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Femur; Fluorouracil; Induction Chemotherapy; Leucovorin; Male; Mice; Mice, Inbred Strains; Muscle, Skeletal; Muscular Dystrophies	2017

Article

Year

ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass.

Scientific reports, 2017, 10-31, Volume: 7, Issue:1

Topics: Activin Receptors, Type II; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Density; Cachexia; Camptothecin; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Femur; Fluorouracil; Induction Chemotherapy; Leucovorin; Male; Mice; Mice, Inbred Strains; Muscle, Skeletal; Muscular Dystrophies

2017